Magill SS, O’Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, et al. Changes in prevalence of health care-associated infections in US hospitals. N Engl J Med. 2018;379:1732–44.

Article  PubMed  PubMed Central  Google Scholar 

Bekaert M, Timsit JF, Vansteelandt S, Depuydt P, Vésin A, Garrouste-Orgeas M, et al. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med. 2011;184:1133–9.

Article  PubMed  Google Scholar 

Micek ST, Wunderink RG, Kollef MH, Chen C, Rello J, Chastre J, et al. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance. Crit Care. 2015;19:219.

Article  PubMed  PubMed Central  Google Scholar 

Falcone M, Venditti M, Shindo Y, Kollef MH. Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia. Int J Infect Dis. 2011;15:e545–50.

Article  PubMed  Google Scholar 

Falcone M, Tiseo G, Giordano C, Leonildi A, Menichini M, Vecchione A, et al. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study. J Antimicrob Chemother. 2021;76:1078–84.

Article  CAS  PubMed  Google Scholar 

Jones BE, Sarvet AL, Ying J, Jin R, Nevers MR, Stern SE, et al. Incidence and Outcomes of non-ventilator-associated hospital-acquired pneumonia in 284 US hospitals using electronic surveillance criteria. JAMA Netw Open. 2023;6: e2314185.

Article  PubMed  PubMed Central  Google Scholar 

Micek ST, Chew B, Hampton N, Kollef MH. A case-control study assessing the impact of nonventilated hospital-acquired pneumonia on patient outcomes. Chest. 2016;150:1008–14.

Article  PubMed  Google Scholar 

Melsen WG, Rovers MM, Koeman M, Bonten MJ. Estimating the attributable mortality of ventilator-associated pneumonia from randomized prevention studies. Crit Care Med. 2011;39:2736–42.

Article  PubMed  Google Scholar 

Zaragoza R, Vidal-Cortés P, Aguilar G, Borges M, Diaz E, Ferrer R, et al. Update of the treatment of nosocomial pneumonia in the ICU. Crit Care. 2020;24:383.

Article  PubMed  PubMed Central  Google Scholar 

Falcone M, Giordano C, Leonildi A, Galfo V, Lepore A, Suardi LR, Riccardi N, Barnini S, Tiseo G. Clinical features and outcomes of infections caused by metallo-β-lactamase–producing enterobacterales: a 3-year prospective study from an endemic area. Clin Infect Dis. 2023;78(5):1111–9. https://doi.org/10.1093/cid/ciad725.

Article  CAS  Google Scholar 

Willems RPJ, van Dijk K, Vehreschild MJGT, Biehl LM, Ket JCF, Remmelzwaal S, et al. Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis. Lancet Infect Dis. 2023;23(6):719–31.

Article  CAS  PubMed  Google Scholar 

Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55.

Article  Google Scholar 

Falcone M, Giordano C, Barnini S, Tiseo G, Leonildi A, Malacarne P, et al. Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020. Euro Surveill. 2020;25:2001779.

Article  PubMed  PubMed Central  Google Scholar 

Falcone M, Tiseo G, Leonildi A, Della Sala L, Vecchione A, Barnini S, et al. Cefiderocol- compared to colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2022;66: e0214221.

Article  PubMed  Google Scholar 

Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF. A Novel Algorithm to analyze epidemiology and outcomes of carbapenem resistance among patients with hospital-acquired and ventilator-associated pneumonia: a retrospective cohort study. Chest. 2019;155:1119–30.

Article  PubMed  Google Scholar 

Chen CY, Yang KY, Peng CK, Sheu CC, Chan MC, Feng JY, et al. Clinical outcome of nosocomial pneumonia caused by carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study. Sci Rep. 2022;12:7501.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falcone M, Bassetti M, Tiseo G, Giordano C, Nencini E, Russo A, et al. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care. 2020;24:29.

Article  PubMed  PubMed Central  Google Scholar 

Falcone M, Russo A, Iacovelli A, Restuccia G, Ceccarelli G, Giordano A, et al. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin Microbiol Infect. 2016;22:444–50.

Article  CAS  PubMed  Google Scholar 

Falcone M, Tiseo G, Carbonara S, Marino A, Di Caprio G, Carretta A, et al. Mortality attributable to bloodstream infections caused by different carbapenem-resistant gram-negative bacilli: results from a nationwide study in Italy (ALARICO Network). Clin Infect Dis. 2023;76:2059–69.

Article  CAS  PubMed  Google Scholar 

Martin-Loeches I, Reyes LF, Nseir S, Ranzani O, Povoa P, Diaz E, et al. European Network for ICU-Related Respiratory Infections (ENIRRIs): a multinational, prospective, cohort study of nosocomial LRTI. Intensive Care Med. 2023;49:1212–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock. Crit Care Med. 2021;49:1974–82.

Article  PubMed  Google Scholar 

Falcone M, Tiseo G, Galfo V, Giordano C, Leonildi A, Marciano E, et al. Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study). Clin Microbiol Infect. 2022;28:298.e1-298.e7.

Article  CAS  PubMed  Google Scholar 

Beuving J, Wolffs PF, Hansen WL, Stobberingh EE, Bruggeman CA, Kessels A, et al. Impact of same-day antibiotic susceptibility testing on time to appropriate antibiotic treatment of patients with bacteraemia: a randomised controlled trial. Eur J Clin Microbiol Infect Dis. 2015;34:831–8.

Article  CAS  PubMed  Google Scholar 

Kim JH, Kim I, Kang CK, Jun KI, Yoo SH, Chun JY, et al. Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trial. Clin Microbiol Infect. 2021;27:69–75.

Article  CAS  PubMed  Google Scholar 

Tumbarello M, Raffaelli F, Giannella M, Mantengoli E, Mularoni A, Venditti M, et al. ceftazidime-avibactam use for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infections: a retrospective observational multicenter study. Clin Infect Dis. 2021;73:1664–76.

Article  CAS  PubMed  Google Scholar 

Shields RK, Nguyen MH, Chen L, Press EG, Kreiswirth BN, Clancy CJ. Pneumonia and renal replacement therapy are risk factors for ceftazidime-avibactam treatment failures and resistance among patients with carbapenem-resistant Enterobacteriaceae Infections. Antimicrob Agents Chemother. 2018;62:e02497-e2517.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tiseo G, Galfo V, Riccardi N, Suardi LR, Pogliaghi M, Giordano C, et al. Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis. 2024 Feb 20. Epub ahead of print